Insider Sale at AxoGen (AXGN) Continues Selling Trend

Tuesday, February 20, 2018 10:15 PM ET

Insider Sale at AxoGen (AXGN) Continues Selling Trend

A filing with the SEC today revealed a significant insider sale of AxoGen shares as — Jamie Mark Grooms, Director — disposed of 63,395 shares in the company having a market value of approximately $1,754,060. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 218,412 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 281,807 shares and have averaged 140,904 shares per transaction over this time period.

The number of insider buy/sell trades at AxoGen is greater than that of the 93 peer company average over the last 90-day period. The Advanced Medical Equipment & Technology peer group saw 101 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by AxoGen insiders is lower than its peers. Within the peer group there were 13,851,894 shares purchased and 712,613 shares sold with company insiders acquiring 196,109 shares on average over this time period.

The data obtained in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.